|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲肿瘤内科协会对宫颈癌的诊断、治疗和随访所制定的临床实践指南显示文摘2010年底,在意大利米兰召开了欧洲肿瘤年会。会上推出了常见妇科肿瘤的诊治指南。这些指南与国际妇产科联盟(FIGO)、美国国立综合癌症网(NCCN)等的指南有一些差异,但细腻周全,有其特点和重要参考价值。现邀请北京协和医院杨华博士翻译,《国际妇产科学杂志》主编郎景和教授审校,依宫颈癌、子宫内膜癌、卵巢上皮癌、非卵巢上皮癌顺序陆续发表,以飨读者。指南均发表于欧洲肿瘤协会(European Society forMedical Oncology,ESMO)主办的肿瘤年刊 Annals of Oncology,2010,21(Suppl 5)。 | Haie-Meder C Morice P Castiglione M On Behalf of the ESMO Guidelines Working Group 杨华 郎景和 | 2011 | 国际妇产科学杂志2011，38，1： | 21 |
| 2 | Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting显示文摘AIM: To validate the Rockall scoring system for predicting outcomes of rebleeding, and the need for a surgical procedure and death. METHODS: We used data extracted from the Registry of Upper Gastrointestinal Bleeding and Endoscopy including information of 1869 patients with non-variceal upper gastrointestinal bleeding treated in Canadian hospitals. Risk scores were calculated and used to classify patients based on outcomes. For each outcome, we used χ2 goodness-of-fit tests to assess the degree of calibration, and built receiver operating characteristic curves and calculated the area under the curve (AUC) to evaluate the discriminative ability of the scoring system. RESULTS: For rebleeding, the χ2 goodness-of-fit test indicated an acceptable fit for the model [χ2 (8) = 12.83, P = 0.12]. For surgical procedures [χ2 (8) = 5.3, P = 0.73] and death [χ2 (8) = 3.78, P = 0.88], the tests showed solid correspondence between observed proportions and predicted probabilities. The AUC was 0.59 (95% CI: 0.55-0.62) for the outcome of rebleeding and 0.60 (95% CI: 0.54-0.67) for surgical procedures, representing apoor discriminative ability of the scoring system. For the outcome of death, the AUC was 0.73 (95% CI: 0.69-0.78), indicating an acceptable discriminative ability. CONCLUSION: The Rockall scoring system provides an acceptable tool to predict death, but performs poorly for endpoints of rebleeding and surgical procedures. | Robert A Enns Yves M Gagnon Alan N Barkun David Armstrong Jamie C Gregor Richard N Fedorak RUGBE Investigators Group | 2006 | World Journal of Gastroenterology2006，12，48： | 14 |
| 3 | 欧洲肿瘤内科协会对非上皮性卵巢癌的诊断、治疗和随访所制定的临床实践指南显示文摘非上皮性卵巢癌是一类少见的卵巢癌,因此,其诊断较难建立。然而,通过仔细观察各种肿瘤的标记物[尤其是人绒毛膜促性腺激素β亚单位(β-hCG)、α-甲胎蛋白(α-AFP)和乳酸脱氢酶(LDH)]、临床体征(如妊娠期体征, | Reed N Millan D Verheijen R Castiglione M On behalf of the ESMO Guidelines Working Group 杨华(译) 郎景和(审校) | 2011 | 国际妇产科学杂志2011，38，4： | 13 |
| 4 | Body-mass index correlates with severity and mortality in acute pancreatitis: A meta-analysis显示文摘BACKGROUND Obesity rates have increased sharply in recent decades. As there is a growing number of cases in which acute pancreatitis(AP) is accompanied by obesity, we found it clinically relevant to investigate how body-mass index(BMI) affects the outcome of the disease.AIM To quantify the association between subgroups of BMI and the severity and mortality of AP.METHODS A meta-analysis was performed using the Preferred Reporting Items for Systematic Review and Meta-Analysis(PRISMA) Protocols. Three databases(PubMed, EMBASE and the Cochrane Library) were searched for articles containing data on BMI, disease severity and mortality rate for AP. Englishlanguage studies from inception to 19 June 2017 were checked against our predetermined eligibility criteria. The included articles reported all AP cases with no restriction on the etiology of the disease. Only studies that classified AP cases according to the Atlanta Criteria were involved in the severity analyses. Odds ratios(OR) and mean differences(MD) were pooled using the random effects model with the DerSimonian-Laird estimation and displayed on forest plots. The meta-analysis was registered in PROSPERO under number CRD42017077890.RESULTS A total of 19 articles were included in our meta-analysis containing data on 9997 patients. As regards severity, a subgroup analysis showed a direct association between AP severity and BMI. BMI < 18.5 had no significant effect on severity;however, BMI > 25 had an almost three-fold increased risk for severe AP in comparison to normal BMI(OR = 2.87, 95%CI: 1.90-4.35, P < 0.001). Importantly,the mean BMI of patients with severe AP is higher than that of the non-severe group(MD = 1.79, 95%CI: 0.89-2.70, P < 0.001). As regards mortality, death rates among AP patients are the highest in the underweight and obese subgroups. A BMI < 18.5 carries an almost two-fold increase in risk of mortality compared to normal BMI(OR = 1.82, 95%CI: 1.32-2.50, P < 0.001). However, the chance of mortality is almost equal in the normal BMI and BMI 25-30 subgroups. A BMI >30 results in a three times higher risk of mortality in comparison to a BMI < 30(OR = 2.89, 95%CI: 1.10-7.36, P = 0.026).CONCLUSION Our findings confirm that a BMI above 25 increases the risk of severe AP, while a BMI > 30 raises the risk of mortality. A BMI < 18.5 carries an almost two times higher risk of mortality in AP. | Dalma Dobszai Péter Mátrai Zoltan Gyongyi Dezso Csupor Judit Bajor Balint Eross Alexandra Mikó Lajos Szakó Agnes Meczker Roland Hágendorn Katalin Márta Andrea Szentesi Péter Hegyi on behalf of the Hungarian Pancreatic Study Group | 2019 | World Journal of Gastroenterology2019，25，6： | 11 |
| 5 | 镍钛形状记忆合金细胞相容性和生物力学兼容性的改进显示文摘镍钛记忆合金(NiTi)生物材料器件的发展,迫切要求研究和提高其细胞相容性和生物力学性能。依据美国材料测试标准协会(ASTM)的标准,我们研究表明:NiTi的细胞毒性比纯钛、Ti6A14V和316L不锈钢大,在NiTi表面作聚合四氟乙烯高离子(PPTFE)喷涂。可降低NiTi合金的细胞毒性,提高其抗腐蚀力。各种热处理方法可改善其疲劳性能,循环拉伸强度试验可测出其超弹性性能的衰减。 | L’H Yahia S.Lombardi N.Hagemeister G.Drouin C.H. Rivard M .Assad Okuyaman(Biomechanical-Biomaterials Research Group, Biomedical Engineering Institute, Ecole Polytechnique de Montreal,Canada)(Department of Orthopaedic Surgery,Hospital St.Justine, Montreal, | 1995 | 医用生物力学1995，10，2： | 9 |
| 6 | 根据血压等级确定脑卒中和冠状动脉粥样硬化性心脏病死亡的终生风险:日本EPOCH(观察队列的心血管预防证据)研究显示文摘在亚洲人群中.很少研究关注根据血压分类确定脑卒中和冠状动脉粥样硬化性心脏病(coronary heartdisease,CHD)的终生风险。该研究旨在用一个包含个体参与者数据的荟萃分析大数据库来评估它。该荟萃分析纳入来源于13个队列的107 737名日本人(男性占42.4%,平均年龄55.1岁)。在平均(15.2±5.3)年(1 559 136人年)的随访期.1922人死于脑卒中,913人死于CHDO研究者在调整其他死亡危险因素后估计风险。 | 陈嘉睿(译) 练桂丽(审校) Satoh M Ohkubo T Asayama K Murakami Y Sugiyama D Yamada M Saitoh S Sakata K Irie F Sairenchi T Ishikawa S Kiyama M Ohnishi H Miura K Imai Y Ueshima H Okamura T EPOCH-JAPAN research group | 2019 | 中华高血压杂志2019，27，4： | 9 |
| 7 | Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial 显示文摘 | Colon Cancer Laparoscopic or Open Resection Study Group Buunen M Veldkamp R | 2009 | Lancet Oncoi2009，10，1： | 1 |
| 8 | Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up 显示文摘 | Kataja V Castiglione M ESMO Guidelines Working Group | 2008 | Ann Oncol2008，19，2： | 1 |
| 9 | Rosiglitazone improves glycemic control without adversely affecting cardiac function in type 2 diabetes显示文摘 | Dole J for the Rosiglitazone Study Group | 1999 | Diabetologia1999，42，1： | 1 |
| 10 | Small-cell lung cancer:ESMO clinical recommendations for diagnosis,treatment and follow-up显示文摘 | S(o)rensen M Felip E ESMO Guidelines Working Group | 2009 | Ann Oncol2009，204，： | 1 |
| 11 | Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention:follow-up of the Finnish Diabetes Prevention Study显示文摘 | Lindstr(o)m J Ilanne-Parikka P Peltonen M : Finnish Diabetes Prevention Study Group | 2006 | Lancet2006，368，9548： | 1 |
| 12 | Survival after laparoscopic surgery versus open surgery for colon cancer: long- term outcome of a randomised clinical trial 显示文摘 | Colon Cancer Laparoscopic or Open Resection Study Group Buunen M Veldkamp R Hop WC | 2009 | Lancet Oncol2009，10，： | 1 |
| 13 | Use of evidence-based practices in pregnancy and child- birth: south east asia optimising reproductive and child health in developing countries project 显示文摘 | SEA-ORCHID Study Group Laopaiboon M Lumbiganon P | 2008 | PLoS One2008，3，7： | 1 |
| 14 | A doubleblind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection显示文摘 | Youle M Osio M ALCAR Study Group | 2007 | HIV Med2007，8，4： | 1 |
| 15 | Survival after laparoscopic surgery versus open surgery for colon cancer; long-term outcome of a randomised clinical trial显示文摘 | Colon Cancer Laparoscopic or Open Resection Study Group Buunen M Veldkamp R | 2009 | Lancet Oncol2009，10，1： | 1 |
| 16 | Aconsensus document on robotic surgery显示文摘 | Herron DM Marohn M SAGES-MIRA Robotic Surgery Consensus Group | 2008 | Surg Endosc2008，22，2： | 1 |
| 17 | Muhicenter study of hospital acquired pneumonia in non - ICU patients 显示文摘 | SOPENA N SABRIA M Neunos 2000 study Group | 2005 | Chest2005，127，1： | 1 |
| 18 | Molecular diagnosis of infective endocarditis by re- al-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue 显示文摘 | Marin M Mufioz P Sdnchez M del Rosal M Alcal6 L Rodrlguez-Cr6ixems M Bouza E Group for the Manage- ment of Infective Endocarditis of the Gregorio Marafi6n Hospital | 2007 | Medicine2007，86，4： | 1 |
| 19 | Reduction of microalbuminuria in patients with type 2 diabetes:the Shiga Microalbuminuria Reduction Trial (SMART)显示文摘 | Shiga Microalbuminuria Reduction Trial (SMART) Group Uzu T Sawaguchi M | | 0，，06： | 1 |
| 20 | Macrolide resistant Mycoplasma pneumoniae in adults with community acquired pneumonia 显示文摘 | Miyashita N Oka M Atypical Pathogen Study Group | 2010 | Int J Antimicrob Agents2010，36，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员